Skip to main content

HUTCHMED (China) Ltd

HCM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001648257

No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.

Other share classesHMDCF

Q3 2022 vs. Q2 2022

How the institutions holding HUTCHMED (China) Ltd changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of HCM: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders1161107−8
Shares48.6M42638.3M−10.3M (−21.1%)
Value$615.9M$5.00K$341.3M−$274.5M (−44.6%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held HUTCHMED (China) Ltd at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to HCM in Q3 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC69,343$614.0K0.00%
FIL Ltd36,040$319.0K0.00%
Balyasny Asset Management LLC19,076$169.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.16,664$148.0K0.00%
Squarepoint Ops LLC14,054$125.0K0.00%
Teacher Retirement System of Texas10,306$91.0K0.00%
Aquatic Capital Management LLC6,400$57.0K0.01%
Quadrant Capital Group LLC508$5.00K0.00%
China Universal Asset Management Co., Ltd.359$3.00K0.00%
1832 Asset Management L.P.258$2.00K0.00%
Community Bank, N.A.67$1.00K0.00%

Sold out (19)

Institutions that held HUTCHMED (China) Ltd at the end of Q2 2022 and filed for Q3 2022 without it.

Not filed for Q3 2022 yet (1)

Institutions that held HUTCHMED (China) Ltd at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HCM in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Private Capital Group, LLC426$5.00K